» Authors » Xianyun Cai

Xianyun Cai

Explore the profile of Xianyun Cai including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 5
Citations 12
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Chen X, Zheng X, Cai X, Wang H, Shan R, Gu Y, et al.
J Magn Reson Imaging . 2025 Jan; PMID: 39781625
Background: Bladder injury during cesarean delivery (CD) in pregnant women with severe placenta accreta spectrum (PAS) disorders mostly occurs in the dissection of vesico-uterine space. Placental MRI may help to...
2.
Zhang C, Zhang K, Hu X, Cai X, Chen Y, Gao F, et al.
Cereb Cortex . 2024 Jan; 34(2). PMID: 38271282
More evidence shows that changes in functional connectivity with regard to brain networks and neurometabolite levels correlated to cognitive impairment in multiple sclerosis. However, the neurological basis underlying the relationship...
3.
Li Y, Gong T, Lin X, Wei X, Cai X, Chen X, et al.
Eur J Radiol . 2023 Oct; 168:111137. PMID: 37856940
Objective: To evaluate pelvic floor muscle injury in patients with levator ani muscle (LAM) weakness after vaginal delivery using T2-parameter mapping. Materials And Methods: 40 parturients (patient group) and 25...
4.
Cai X, Chen X, Wang J, Wei X, Liu W, Li Y, et al.
Prenat Diagn . 2022 Sep; 42(11):1398-1408. PMID: 36097375
Objective: To evaluate the performance of susceptibility-weighted imaging (SWI) in visualizing normal and abnormal fetal vertebrae in vivo and in utero. Methods: Ninety-seven women with normal fetal vertebrae and 127...
5.
Cai X, Chen X, Wei X, Liu W, Hou X, Gong T, et al.
Quant Imaging Med Surg . 2022 Jun; 12(6):3391-3405. PMID: 35655821
Background: Magnetic resonance imaging (MRI) has been used increasingly as an adjunct examination to ultrasound (US) for the evaluation of fetal anomalies. The purpose of this study was to determine...
6.
Xie H, Wang H, Xu L, Li M, Peng Y, Cai X, et al.
Clin Lung Cancer . 2018 Oct; 19(6):484-492. PMID: 30369426
Background: The superior efficacy of first-line treatment with gefitinib over that of standard chemotherapy was demonstrated in patients with advanced non-small-cell lung cancer (NSCLC) harboring sensitive mutation of epidermal growth...